PAB 16.7% 0.7¢ patrys limited

The problem with PAB is it cannot sustain its SP without some...

  1. 180 Posts.
    lightbulb Created with Sketch. 34

    The problem with PAB is it cannot sustain its SP without some form of partnering or sponsorship with Big Pharma and/or positive human Clinical Trial results. Until then I wouldn't be surprised to see it drift into the 1-2 range.

    A lot of patience is required as there is a very long way to go yet. Its just a traders game at the moment.

    I have held this stock for 7 years now, and progressively averaging down. I'll be keeping an eye on the Cash in Bank situation, as soon as they need more $$$ you can bet there will be a flurry of positive announcements.

 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $14.40M
Open High Low Value Volume
0.6¢ 0.7¢ 0.6¢ $2.505K 375.8K

Buyers (Bids)

No. Vol. Price($)
9 4356781 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 2239285 4
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.